CEACAM1 promotes CD8<sup>+</sup> T cell responses and improves control of a chronic viral infection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29967450.
- Also identified by DOI 10.1038/s41467-018-04832-2 and PMC identifier 6028648.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Dysfunction of CD8<sup>+</sup> T cells can lead to the development of chronic viral infection. Identifying mechanisms responsible for such T cell dysfunction is therefore of great importance to understand how to prevent persistent viral infection. Here we show using lymphocytic choriomeningitis virus (LCMV) infection that carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is fundamental for recruiting lymphocyte-specific protein kinase (Lck) into the T cell receptor complex to form an efficient immunological synapse. CEACAM1 is essential for activation of CD8<sup>+</sup> T cells, and the absence of CEACAM1 on virus-specific CD8<sup>+</sup> T cells limits the antiviral CD8<sup>+</sup> T cell response. Treatment with anti-CEACAM1 antibody stabilizes Lck in the immunological synapse, prevents CD8<sup>+</sup> T cell exhaustion, and improves control of virus infection in vivo. Treatment of human virus-specific CD8<sup>+</sup> T cells with anti-CEACAM1 antibody similarly enhances their proliferation. We conclude that CEACAM1 is an important regulator of virus-specific CD8<sup>+</sup> T cell functions in mice and humans and represents a promising therapeutic target for modulating CD8<sup>+</sup> T cells.
Medical subject headings
- Antigens, CD
- CD8-Positive T-Lymphocytes
- Carcinoembryonic Antigen
- Cell Adhesion Molecules
- Lymphocytic Choriomeningitis
- Lymphocytic choriomeningitis virus